La Jolla Pharmaceutical Co. is
a biopharmaceutical company engaged in the discovery, development and commercialization of therapeutics for chronic organ failure and cancer.
Adamis Pharmaceuticals Corp is is
a biopharmaceutical company engaged in the development and commercialization of specialty pharmaceutical and biotechnology products in the therapeutic areas of respiratory disease, allergy, oncology and immunology.
AVGN (website here) is a «
biopharmaceutical company engaged in developing and commercializing small molecule therapeutics to treat neurological and neuromuscular disorders.»
Chemocentryx, Inc. is
a biopharmaceutical company engaged in discovering, developing and commercializing orally - administered therapeutics to treat autoimmune diseases, inflammatory disorders and cancer.
PNP Therapeutics ®, Inc., is an early - stage,
biopharmaceutical company engaged in the development of a platform technology and proprietary products for the treatment of cancer.
Not exact matches
NanoViricides, Inc., a development stage nano -
biopharmaceutical company,
engages in the discovery, development, and commercialization of anti-viral therapeutics primarily in the United States.
Horizon Pharma Plc is a specialty
biopharmaceutical company, which
engages in the business of identifying, developing, acquiring and commercializing differentiated products that address unmet medical needs.
Bristol - Myers Squibb
Company is a global
biopharmaceutical Company, which is
engaged in the discovery, development, licensing, manufacturing, marketing, distribution and sale of pharmaceutical products on a global basis.
Nektar Therapeutics, Inc. is clinical - stage
biopharmaceutical Company, which is
engaged in the development of drug candidates that utilize its PEGylation & advanced polymer conjugate technology platforms.
Radius Health, Inc. a
biopharmaceutical company, which
engages in the discovery and development of therapeutics for the treatment of osteoporosis and other women's health conditions.
FTSE 100
biopharmaceutical company Shire, led by director of legal strategy Claire Debney (pictured top left) and legal strategy manager Ama Zbarcea, has conducted an extensive sandbox exercise to
engage its staff in the selection of a contract management system, as part of a much wider technologyled transformation programme.
Shire's CSO leads tech transformation programme FTSE 100
biopharmaceutical company Shire, led by chief strategy officer Claire Debney and legal strategy manager Ama Zbarcea, has conducted an extensive sandbox exercise to
engage its staff in the selection of a contract management system, as part of a much wider technology - led transformation programme.